Science & Tech
Could an Antibody Drug Revolutionize Treatment for Lung Cancer?
A groundbreaking study reveals that an antibody drug, SHR-4849, may significantly improve treatment outcomes for patients with relapsed small-cell lung cancer. With promising early results and…